Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |